CASC
Cascadian Therapeutics, Inc.
Set alert
No live quote for CASC yet.
- Open
- 10.00
- Prev close
- 10.02
- Mkt cap
- 0
- Vol
- 2.00K
- Avg vol
- 0
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 9.99
- High
- 10.03
- Forward P/E
- 0.00
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.00
- 200-d avg
- 0.00
Key statistics
- Market cap
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- Price / sales
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
CASC Revenue — quarterly 0
CASC Net income — quarterly -16.76M
CASC EPS — quarterly -0.34
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 6, 2017 | Barclays | init | — | Underweight |
| Apr 20, 2017 | BTIG Research | init | — | Buy |
| Feb 21, 2012 | Global Hunter Securities | down | — | Accumulate |
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on CASC — it syncs with the Stock Master app.